response to stress. Yet, despite its obvious importance, little is known regarding even the identity (or the function) of the intracellular molecular pathways underpinning the trafficking and targeting of integral membrane proteins in the context of the native heart. The goal of this work is identify new molecular players that regulate protein targeting and trafficking in the heart. Eps 15 homology domain-containing (EHD) gene products (EHD1-4) are intracellular proteins that are key regulators of endosomal trafficking, lipid homeostasis, membrane protein recycling and trafficking. Previously uncharacterized in the heart, we recently presented evidence which demonstrated that this protein family likely plays indispensable roles in protein trafficking in cardiac muscle. Notably, an essential role for one of these proteins, EHD3, in the membrane trafficking of the Na/Ca exchanger (NCX) in heart was uncovered. The goal of this research program is for the first time to directly test the role of these proteins in cardiac structural and electrical activity using cutting-edge in vivo models of EHD deficiency. We show that EHD3 deficiency in the heart leads to: 1) abnormal cardiac structure at baseline; 2) irregular action potential morphology, heart rhythm, and conduction; 3) depressed b-adrenergic responsiveness; 4) dysfunctional NCX and LTCC trafficking and function; and 5) dysregulated ankyrin-B expression and trafficking. These data strongly support a role for EHD3 in membrane protein trafficking and regulation within the context of the native heart. In skeletal muscle, the calcium binding protein calmodulin (CaM) plays an essential role in excitation-contraction coupling by modulating the opening and closing of the calcium channel ryanodine receptor (RyR1). Biochemical studies have mapped the CaM binding site (CaMBD) to a short region on RyR1 comprising residues 3614-3643. By interacting with this region differently at high and low calcium, CaM acts as a 'switch', providing essential feedback in Ca 2þ levels during muscle contraction. Our X-ray structure of Ca 2þ -CaM bound to RyR1 CaMBD (2BCX) revealed a novel '1-17' motif of RyR1 hydrophobic amino-acids anchoring the CaM domains. In order to gain additional insights into the CaM-RyR1 interaction, we are pursuing thermodynamic studies of CaM-RyR1 CaMBD complexes at several Ca 2þ concentrations. The energy of interaction between CaM and RyR1 CaMBD was determined using Förster resonance energy transfer in an auto-fluorescent biosensor construct (YFP-CaMBD-CFP). Fluorescence titrations at increasing concentrations of CaM enabled us to determine association constants and free energies of binding at high and low calcium. Interestingly, the affinities of apo-and Ca 2þ -CaM for RyR1 CaMBD differed by orders of magnitude (micromolar vs. subnanomolar). Mutational analysis was performed for RyR1 residues W3620 and F3636 which form close contacts with the CaM C-and N-domains in the 2BCX complex. Both in the presence and absence of calcium, mutation of W3620 to alanine resulted in significant effects on the binding affinity, while the F3636 mutation had weaker effects. Titrations with the individual CaM domains and CaM calcium-binding mutants show that the CaM C-domain is the main mediator of interaction. Future studies will further explore residue-specific differences in CaM-RyR1 recognition and the interplay between the processes of calcium-and target-binding to CaM. Funding: Drake University, NIH R01 GM57001, University of Iowa FUTURE in Biomedicine program.
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Biochemistry and Molecular Biology, University of Texas Medical School, Houston, TX, USA, 2 Neurobiology and Anatomy, University of Texas Medical School, Houston, TX, USA. Background: Neurogranin (Ng) and PEP-19 are small proteins with no known intrinsic activity other than binding to calmodulin (CaM) via their IQ motifs, yet they have been implicated in numerous normal and pathological processes. We showed that PEP-19 is intrinsically disordered, and that an acidic sequence adjacent to its IQ motif is required for PEP-19 to modulate Ca 2þ binding to CaM, and to sensitize HeLa cells to ATP-induced Ca 2þ release. Goals: Ng has an acidic sequence, but with significantly different composition than PEP-19. Thus, the goals of the current study were to determine: 1) If the acidic sequence in Ng is required to modulate Ca 2þ binding to CaM; and 2) Use NMR to compare the effects of Ng derivatives on the conformation of CaM. Results: Ng greatly increases the Ca 2þ koff at the C-domain of CaM, but has little effect on the kon, thereby decreasing Ca 2þ binding affinity. In skeletal muscle, the calcium binding protein calmodulin (CaM) plays an essential role in excitation-contraction coupling by modulating the opening and closing of the calcium channel ryanodine receptor (RyR1). Biochemical studies have mapped the CaM binding site (CaMBD) to a short region on RyR1 comprising residues 3614-3643. By interacting with this region differently at high and low calcium, CaM acts as a 'switch', providing essential feedback in Ca 2þ levels during muscle contraction. Our X-ray structure of Ca 2þ -CaM bound to RyR1 CaMBD (2BCX) revealed a novel '1-17' motif of RyR1 hydrophobic amino-acids anchoring the CaM domains. In order to gain additional insights into the CaM-RyR1 interaction, we are pursuing thermodynamic studies of CaM-RyR1 CaMBD complexes at several Ca 2þ concentrations. The energy of interaction between CaM and RyR1 CaMBD was determined using Förster resonance energy transfer in an auto-fluorescent biosensor construct (YFP-CaMBD-CFP). Fluorescence titrations at increasing concentrations of CaM enabled us to determine association constants and free energies of binding at high and low calcium. Interestingly, the affinities of apo-and Ca 2þ -CaM for RyR1 CaMBD differed by orders of magnitude (micromolar vs. subnanomolar). Mutational analysis was performed for RyR1 residues W3620 and F3636 which form close contacts with the CaM C-and N-domains in the 2BCX complex. Both in the presence and absence of calcium, mutation of W3620 to alanine resulted in significant effects on the binding affinity, while the F3636 mutation had weaker effects. Titrations with the individual CaM domains and CaM calcium-binding mutants show that the CaM C-domain is the main mediator of interaction. Future studies will further explore residue-specific differences in CaM-RyR1 recognition and the interplay between the processes of calcium-and target-binding to CaM. Funding: Drake University, NIH R01 GM57001, University of Iowa FUTURE in Biomedicine program. University of Minnesota, Minneapolis, MN, USA. Calmodulin (CaM) binding to RyR2 inhibits diastolic channel activity, indicating that CaM stabilizes RyR2 in the closed state. In conditions where CaM dissociates from RyR2, like heart failure (HF), RyR2 exhibits destabilized gating and increased activity. Those characteristics make CaM a critical regulator of RyR2 and potential therapeutic target for HF. Another leading mechanism for the RyR2 dysfunction in HF is defective domain interaction between N-terminal (N: 0-600) and central (C: 2000-2500) domains. However, the relationship between CaM-RyR2 binding and defective domain interaction in HF is unclear, especially in cardiomyocytes. Here, in cardiomyocytes from rat with HF induced by coronary ligation, we use FRET between fluorescent FKBP12.6 and CaM to specifically detect RyR2-bound CaM and measure the RyR2-CaM binding affinity. In steady-state binding affinity measurements, the Kd for CaM-RyR2 binding in HF myocytes is~51 nM, which is~3 fold increased vs. normal myocytes. By measuring the binding kinetics of fluorescent domain peptide DPc10 (F-DPc10), we can detect defective interaction between N-terminal and central domains in myocytes. In HF myocytes, the F-DPc10-RyR2 association rate was significantly accelerated vs. normal myocytes, indicating a destabilized domain interaction (unzipping). However, in HF myocytes, saturating RyR2 with high [CaM] dramatically reduced F-DPc10 binding to RyR2 (B max ) and greatly slowed the association rate (k on ). We conclude that in HF myocytes, reduced CaM-RyR2 binding affinity leads to defective domain interaction, shifting the channel to an ''unzipped'' state'. Promoting CaM-RyR2 reassociation can restore the defective domain interaction and stabilize the channel. Tuesday, February 18, 2014 527a 
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